I'm Naymul Hasan, and I've been working in government contracting for over 5 years. During this time, I've gained hands-on experience navigating federal procurement processes, managing contracts, and ensuring full compliance with government regulations. I specialize in proposal development, vendor coordination, and delivering value-driven solutions that meet the unique needs of public sector clients. I'm passionate about helping organizations succeed in the complex world of government contracting.
In the high-stakes world of federal government contracting, past performance isn’t just a checkbox – it’s a credibility currency. For small businesses aiming to break into or scale within the federal marketplace, understanding how agencies evaluate past performance can be the difference between a winning bid and a missed opportunity. Whether you’re bidding as a…
Mastering Cost Realism Analysis in Federal Contracting Cost realism analysis is more than a pricing checkpoint. It’s a compliance gate, a performance predictor, and a silent deal-breaker. Under FAR 15.404-1(d), federal agencies use cost realism to assess whether proposed costs reflect the actual effort required. Cost Realism vs Price Reasonableness, Know the Difference Many contractors…
Winning your first government contract feels like climbing a mountain — thrilling, exhausting, and a little surreal. But here’s the truth: landing that first deal is just the beginning. The real challenge is scaling in government contracting — transforming a small operation into a sustainable, multi-million-dollar enterprise. Most small businesses enter the government space with…
In a major boost to American manufacturing, Stellantis has unveiled plans for a massive $10 billion U.S. auto investment aimed at reviving plants, launching new vehicle lines, and expanding its EV production capacity. This bold step signals a strong vote of confidence in the future of American car manufacturing at a time when the industry…
A growing number of foreign companies are ramping up their U.S. presence to sidestep rising tariffs and trade tensions. With new import duties impacting everything from electronics to heavy machinery, international manufacturers are finding it smarter—and more profitable—to build, hire, and produce directly in the United States. This surge in U.S. presence reflects not only…
Rise of Digital Compliance in U.S. Industries The U.S. industry is undergoing a massive shift — one where technology and regulation are meeting head-on. This new era of digital compliance is changing how companies manage risk, report data, and maintain transparency. It’s no longer enough to just follow the rules manually; now, compliance must evolve…
In a major move signalling confidence in U.S. manufacturing growth, Siemens has announced a $285 million investment to expand its production capabilities across the United States. This investment will primarily focus on enhancing facilities in California and Texas—key states driving innovation in electrification, automation, and artificial intelligence. The announcement reflects Siemens’ long-term commitment to strengthening…
Change is sweeping across America’s business landscape, and at the heart of it lies one big theme — industry compliance. The federal government has been rolling out a wave of new regulations aimed at tightening standards, ensuring transparency, and holding organizations more accountable than ever before. Whether it’s environmental standards, data privacy laws, or labour…
The U.S. government officially entered a shutdown at midnight on October 1, 2025, following a breakdown in budget negotiations between Congress and the White House. As a result, over 750,000 federal employees are being furloughed daily, while essential personnel—including active-duty military—must continue working without pay. The ripple effects are being felt most acutely by military…
On October 3, 2025, President Trump announced a sweeping drug pricing initiative called “TrumpRx,” designed to deliver up to 60% discounts on select medications purchased through federal health programs. The plan includes direct price negotiations with manufacturers, importation of lower-cost drugs from approved countries, and expanded use of biosimilars to reduce dependency on high-cost brand-name…